These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 26412785
1. Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia. Zhu H, Yang X, Ding Y, Liu J, Lu J, Zhan L, Qin Q, Zhang H, Chen X, Yang Y, Yang Y, Liu Z, Yang M, Zhou X, Cheng H, Sun X. Sci Rep; 2015 Sep 28; 5():14503. PubMed ID: 26412785 [Abstract] [Full Text] [Related]
2. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN, Zhu H, Zhang HJ, Zhang WF, Jin HL, Wang L, Wang P, He GJ, Hao B, Shi RH. World J Gastroenterol; 2014 Dec 21; 20(47):17894-904. PubMed ID: 25548487 [Abstract] [Full Text] [Related]
4. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo. Yang X, Yang B, Cai J, Zhang C, Zhang Q, Xu L, Qin Q, Zhu H, Ma J, Tao G, Cheng H, Sun X. Cancer Biol Ther; 2013 Nov 21; 14(11):1068-73. PubMed ID: 24025355 [Abstract] [Full Text] [Related]
5. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, Zeng ZL, Chen J, Cao TT, Ban X, Qian C, Cai Z, Xie D, Huang P, Guan XY. Gastroenterology; 2014 Jun 21; 146(7):1701-13.e9. PubMed ID: 24561231 [Abstract] [Full Text] [Related]
6. Endostatin combined with radiotherapy suppresses vasculogenic mimicry formation through inhibition of epithelial-mesenchymal transition in esophageal cancer. Chen X, Zhang H, Zhu H, Yang X, Yang Y, Yang Y, Min H, Chen G, Liu J, Lu J, Cheng H, Sun X. Tumour Biol; 2016 Apr 21; 37(4):4679-88. PubMed ID: 26511968 [Abstract] [Full Text] [Related]
7. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins. Wang D, Qin Q, Jiang QJ, Wang DF. J Xray Sci Technol; 2016 Apr 13; 24(4):639-46. PubMed ID: 27080362 [Abstract] [Full Text] [Related]
8. Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: experimental and clinical evidence. Meng MB, Jiang XD, Deng L, Na FF, He JZ, Xue JX, Guo WH, Wen QL, Lan J, Mo XM, Lang JY, Lu Y. Radiother Oncol; 2013 Jan 13; 106(1):130-7. PubMed ID: 23351845 [Abstract] [Full Text] [Related]
9. VEGF expression is regulated by HIF-1α and ARNT in 3D KYSE-70, esophageal cancer cell spheroids. Terashima J, Sampei S, Iidzuka M, Ohsakama A, Tachikawa C, Satoh J, Kudo K, Habano W, Ozawa S. Cell Biol Int; 2016 Nov 13; 40(11):1187-1194. PubMed ID: 27542820 [Abstract] [Full Text] [Related]
10. Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression. Ge Y, Liu J, Yang X, Zhu H, Yang B, Zhao K, Wu Z, Cheng G, Wang F, Ni F, Ge Q, Yang Y, Tai G, Sun X, Cai J. Tumour Biol; 2014 Nov 13; 35(11):10765-71. PubMed ID: 25073512 [Abstract] [Full Text] [Related]
11. Inhibition effects of all trans-retinoic acid on the growth and angiogenesis of esophageal squamous cell carcinoma in nude mice. Lu TY, Li WC, Chen RY, Fan QX, Wang LX, Wang RL, Lu SX, Meng H. Chin Med J (Engl); 2011 Sep 13; 124(17):2708-14. PubMed ID: 22040429 [Abstract] [Full Text] [Related]
12. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof]. Yu ZT, Zhao HF, Shang XB. Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2465-9. PubMed ID: 19080625 [Abstract] [Full Text] [Related]
13. STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α. Zhang C, Yang X, Zhang Q, Guo Q, He J, Qin Q, Zhu H, Liu J, Zhan L, Lu J, Liu Z, Xu L, Ma J, Dai S, Cheng H, Sun X. Tumour Biol; 2014 Oct 16; 35(10):9793-9. PubMed ID: 24981247 [Abstract] [Full Text] [Related]
14. Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development. Sato S, Yamamoto H, Mukaisho K, Saito S, Hattori T, Yamamoto G, Sugihara H. PLoS One; 2014 Oct 16; 9(2):e88831. PubMed ID: 24551170 [Abstract] [Full Text] [Related]
15. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE2. Pun IH, Chan D, Chan SH, Chung PY, Zhou YY, Law S, Lam AK, Chui CH, Chan AS, Lam KH, Tang JC. Cancer Res Treat; 2017 Jan 16; 49(1):219-229. PubMed ID: 27456944 [Abstract] [Full Text] [Related]
16. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549. Li ZY, Zhu F, Hu JL, Peng G, Chen J, Zhang S, Chen X, Zhang RG, Chen LJ, Liu P, Luo M, Sun ZH, Ren JH, Huang LL, Wu G. Tumour Biol; 2011 Aug 16; 32(4):677-87. PubMed ID: 21442281 [Abstract] [Full Text] [Related]
17. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells. Fu S, Jin L, Gong T, Pan S, Zheng S, Zhang X, Yang T, Sun Y, Wang Y, Guo J, Hui B, Zhang X. Oncol Rep; 2018 Apr 16; 39(4):1601-1608. PubMed ID: 29393484 [Abstract] [Full Text] [Related]
18. Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Pore N, Gupta AK, Cerniglia GJ, Jiang Z, Bernhard EJ, Evans SM, Koch CJ, Hahn SM, Maity A. Cancer Res; 2006 Sep 15; 66(18):9252-9. PubMed ID: 16982770 [Abstract] [Full Text] [Related]
19. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, Tajiri T, Kudo M, Ishiwata T, Naito Z. Exp Mol Pathol; 2005 Apr 15; 78(2):123-30. PubMed ID: 15713437 [Abstract] [Full Text] [Related]
20. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy. Wang XB, Jiang XR, Yu XY, Wang L, He S, Feng FY, Guo LP, Jiang W, Lu SH. Cancer Sci; 2014 Feb 15; 105(2):176-85. PubMed ID: 24383865 [Abstract] [Full Text] [Related] Page: [Next] [New Search]